Storage and handling
Tamper resistant for your protection. Use only if safety seal is intact
Tamper resistant for your protection. Use only if safety seal is intact
Relieves allergies common in the Northeastern U.S.
Drug Facts
Active Ingredients: Equal volumes of each ingredient in 12X, 30X, and LM1 potencies: Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin, Agraphis nutans, Allium cepa, Collinsonia canadensis, Cortisone aceticum, Euphrasia officinalis, Galphimia glauca, Histaminum hydrochloricum, Kali muriaticum, Mucosa nasalis suis, Natrum muriaticum, RNA, Rumex crisp, Sabadilla, Salvia officinalis, Tanacetum vulgare, Trofolium pratense, Vinca minor
Uses: For temporary relief of symptoms: itchy, watery eyes, sore throat, cough, runny nose, sneezing, congestion, headaches, hoarseness, and fatigue
Warnings:Stop use and ask a doctor if symptoms persist or worsen
If pregnant or breastfeeding, ask a health professional before use
Keep this and all medication out of reach of children
In case of overdose, get medical help or contact a Poison Control Center right away
Directions: Initially, depress pump until primed. Hold close to mouth and spray directly into mouth. Use 3 times daily. Use additionally as needed. Adults: 3 pump sprays. Children 2-12: 2 pump sprays
Inactive Ingredients: Citric acid, potassium sorbate, pure water
The letters HPUS indicate that the components in this products are officially monographed in the Homeopathic Pharmacopoeia of the United States.
All Native Remedies health products are especially formulated by experts in the field of natural health and are manufactured according to the highest pharmaceutical standards for maximum safety and effectiveness. For more information, visit us at
www.nativeremedies.com
Distributed by
Native Remedies, LLC
6531 Park of Commerce Blvd.
Suite 160
Boca Raton, FL 33487
Phone: 1.877.289.1235
International: 1.561.999.8857
No gluten, artificial flavors, or colorants added
Tamper resistant for your protection. Use only if safety seal is intact
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68703-103-59 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1297-f424-e053-dadaa90a57ce | AllergyEase Northeastern |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68703-103-59 | AllergyEase Northeastern | 59 mL in 1 BOTTLE, GLASS | SPRAY | 59 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68703-103 | ALLERGYEASE NORTHEASTERN (ADENOSINUM CYCLOPHOSPHORICUM, ADRENALINUM, ADRENOCORTICOTROPHIN, AGRAPHIS NUTANS, ALLIUM CEPA, COLLINSONIA CANADENSIS, CORTISONE ACETICUM, EUPHRASIA OFFICINALIS, GALPHIMIA GLAUCA, HISTAMINUM HYDROCHLORICUM, KALI MURIATICUM, MUCOSA NASALIS SUIS, NATRUM MURIATICUM, RNA, RUMEX CRISP, SABADILLA, SALVIA OFFICINALIS, TANACETUM VULGARE, TROFOLIUM PRATENSE, VINCA MINOR) SPRAY [NATIVE REMEDIES, LLC] | 1 | Legacy NDC, 1 package rows | 20130628_bf109d9f-aad4-46cd-ab32-3fd1dead07bb.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ADENOSINE CYCLIC PHOSPHATE | ACTIVE INGREDIENT | E0399OZS9N | 1 | |
| COLLINSONIA CANADENSIS ROOT | ACTIVE INGREDIENT | O2630F3XDR | 1 | |
| CORTICOTROPIN | ACTIVE INGREDIENT | K0U68Q2TXA | 1 | |
| CORTISONE ACETATE | ACTIVE INGREDIENT | 883WKN7W8X | 1 | |
| EPINEPHRINE | ACTIVE INGREDIENT | YKH834O4BH | 1 | |
| EUPHRASIA STRICTA | ACTIVE INGREDIENT | C9642I91WL | 1 | |
| GALPHIMIA GLAUCA FLOWERING TOP | ACTIVE INGREDIENT | 93PH5Q8M7E | 1 | |
| HISTAMINE DIHYDROCHLORIDE | ACTIVE INGREDIENT | 3POA0Q644U | 1 | |
| HYACINTHOIDES NON-SCRIPTA | ACTIVE INGREDIENT | 5F658PFU56 | 1 | |
| ONION | ACTIVE INGREDIENT | 492225Q21H | 1 | |
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | 1 | |
| RUMEX CRISPUS ROOT | ACTIVE INGREDIENT | 9N1RM2S62C | 1 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE INGREDIENT | J17GBZ5VGX | 1 | |
| SAGE | ACTIVE INGREDIENT | 065C5D077J | 1 | |
| SCHOENOCAULON OFFICINALE SEED | ACTIVE INGREDIENT | 6NAF1689IO | 1 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| SUS SCROFA NASAL MUCOSA | ACTIVE INGREDIENT | ID3Z1X61WY | 1 | |
| TANACETUM VULGARE TOP | ACTIVE INGREDIENT | D52957JQ8M | 1 | |
| TRIFOLIUM PRATENSE FLOWER | ACTIVE INGREDIENT | 4JS0838828 | 1 | |
| VINCA MINOR | ACTIVE INGREDIENT | WGM46PQF02 | 1 | |
| ADENOSINE CYCLIC PHOSPHATE | ACTIVE MOIETY | E0399OZS9N | 1 | |
| CHLORIDE ION | ACTIVE MOIETY | Q32ZN48698 | 1 | |
| COLLINSONIA CANADENSIS ROOT | ACTIVE MOIETY | O2630F3XDR | 1 | |
| CORTICOTROPIN | ACTIVE MOIETY | K0U68Q2TXA | 1 | |
| CORTISONE | ACTIVE MOIETY | V27W9254FZ | 1 | |
| EPINEPHRINE | ACTIVE MOIETY | YKH834O4BH | 1 | |
| EUPHRASIA STRICTA | ACTIVE MOIETY | C9642I91WL | 1 | |
| GALPHIMIA GLAUCA FLOWERING TOP | ACTIVE MOIETY | 93PH5Q8M7E | 1 | |
| HISTAMINE | ACTIVE MOIETY | 820484N8I3 | 1 | |
| HYACINTHOIDES NON-SCRIPTA | ACTIVE MOIETY | 5F658PFU56 | 1 | |
| ONION | ACTIVE MOIETY | 492225Q21H | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | 1 | |
| RUMEX CRISPUS ROOT | ACTIVE MOIETY | 9N1RM2S62C | 1 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE MOIETY | J17GBZ5VGX | 1 | |
| SAGE | ACTIVE MOIETY | 065C5D077J | 1 | |
| SCHOENOCAULON OFFICINALE SEED | ACTIVE MOIETY | 6NAF1689IO | 1 | |
| SUS SCROFA NASAL MUCOSA | ACTIVE MOIETY | ID3Z1X61WY | 1 | |
| TANACETUM VULGARE TOP | ACTIVE MOIETY | D52957JQ8M | 1 | |
| TRIFOLIUM PRATENSE FLOWER | ACTIVE MOIETY | 4JS0838828 | 1 | |
| VINCA MINOR | ACTIVE MOIETY | WGM46PQF02 | 1 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68703-103 | 68703-103-59 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | OINTMENT / TOPICAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION/ DROPS / ORAL | 19 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / RECTAL | 7 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY / NASAL | 9 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / ORAL | 269 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / TOPICAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SWAB / TOPICAL | 0.05 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOAP / TOPICAL | 0.5 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAMUSCULAR | 28 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | LOTION / TOPICAL | 0.2 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DROPS / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / INTRAVENOUS | 0.2 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CREAM / TOPICAL | 0.25 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / RESPIRATORY (INHALATION) | 0.03 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | EMULSION / TOPICAL | 0.11 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SUBCUTANEOUS | 28 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | AEROSOL, FOAM / TOPICAL | 8 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SYRUP / ORAL | 2 mg/1ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SUSPENSION / ORAL | 840 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EXTENDED RELEASE / ORAL | 45 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / OPHTHALMIC | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRATHECAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAVENOUS | 396 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / ORAL | 1000 mg/15ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / TOPICAL | 0.01 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRASYNOVIAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | ELIXIR / ORAL | 100 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / OPHTHALMIC | 0.03 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CAPSULE / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / AURICULAR (OTIC) | 0.2 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GEL / TOPICAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / ORAL | 114 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GRANULE, FOR SUSPENSION / ORAL | 113 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION, EXTENDED RELEASE / ORAL | 140.8 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYRUP / ORAL | 722 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / TOPICAL | 4 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, COATED / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / SUBLINGUAL | 24 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / VAGINAL | 0.49 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / ORAL | 315 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TROCHE / ORAL | 12 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / RESPIRATORY (INHALATION) | 0.13 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / EPIDURAL | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / AURICULAR (OTIC) | 0.04 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAVENOUS | 2068 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / RESPIRATORY (INHALATION) | 8 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING / ORAL | 83 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRACARDIAC | 1.05 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | PASTE / ORAL | 48 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAOCULAR | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / ORAL | 914 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / RECTAL | 6.67 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / TOPICAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DOUCHE / VAGINAL | 0.07 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRA-ARTICULAR | ADJ PH |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 674ea646-d803-4587-a937-8202693c37e6 | bf109d9f-aad4-46cd-ab32-3fd1dead07bb | 2013-06-27 | Warnings | 674ea646-d803-4587-a937-8202693c37e6 bf109d9f-aad4-46cd-ab32-3fd1dead07bb |
Adverse event summaries are temporarily unavailable. Other product information remains available.